26
Informaciones
Psiquiátricas
2014-n.º 216
Jorge López Álvarez / Luis Fernando Agüera Ortiz
20. Ligthart SA, Richard E, Fransen NL,
Eurelings LS, Beem L, Eikelenboom P, et
al. Association of vascular factors with
apathy in community-dwelling elderly
individuals. Arch Gen Psychiatry. 2012
Jun;69(6):636-42. doi: 10.1001/ar-
chgenpsychiatry.2011.1858.
21. Mulin E, Leone E, Dujardin K, Delliaux
M, Leentjens A, Nobili F, et al. Diag-
nostic criteria for apathy in clinical
practice. Int J Geriatr Psychiatry.
2011 Feb;26(2):158-65. doi: 10.1002/
gps.2508.
22. Peters ME, Rosenberg PB, Steinberg M,
Tschanz JT, Norton MC, Welsh-Bohmer
KA, et al; Cache County Investigators.
Prevalence of neuropsychiatric symptoms
in CIND and its subtypes: the Cache
County Study. Am J Geriatr Psychiatry.
2012 May;20(5):416-24. doi: 10.1097/
JGP.0b013e318211057d.
23. Zahodne LB, Bernal-Pacheco O, Bowers
D, Ward H, Oyama G, Limotai N,et al.
Are selective serotonin reuptake inhi-
bitors associated with greater apathy
in Parkinson’s disease? J Neurop-
sychiatry Clin Neurosci. 2012 Sum-
mer;24(3):326-30. doi: 10.1176/appi.
neuropsych.11090210.
24. Caeiro L, Ferro JM, Costa J. Apathy
secondary to stroke: a systematic
review and meta-analysis. Cerebro-
vasc Dis. 2013;35(1):23-39. doi:
10.1159/000346076. Epub 2013 Feb
14.
25. Treiber KA, Lyketsos CG, Corcoran C,
Steinberg M, Norton M, Green RC, et
al. Vascular factors and risk for neu-
ropsychiatric symptoms in Alzheimer’s
disease: the Cache County Study. Int
Psychogeriatr. 2008 Jun;20(3):538-53.
doi: 10.1017/S1041610208006704.
Epub 2008 Feb 21.
26. Vilalta-Franch J, Calvó-Perxas L, Garre-
Olmo J, Turró-Garriga O, López-Pousa S.
Apathy syndrome in Alzheimer’s disease
epidemiology: prevalence, incidence,
persistence, and risk and mortality fac-
tors. J Alzheimers Dis. 2013;33(2):535-
43. doi: 10.3233/JAD-2012-120913.
27. Benoit M, Berrut G, Doussaint J, Bak-
chine S, Bonin-Guillaume S, Frémont
P, et al. Apathy and depression in mild
Alzheimer’s disease: a cross-sectional
study using diagnostic criteria. J Al-
zheimers Dis. 2012;31(2):325-34. doi:
10.3233/JAD-2012-112003.
28. van Duijn E, Kingma EM, van der
Mast RC. Psychopathology in verified
Huntington’s disease gene carriers. J
Neuropsychiatry Clin Neurosci. 2007
Fall;19(4):441-8. Review.
29. van Duijn E, Reedeker N, Giltay EJ,
Roos RA, van der Mast RC. Correlates
of apathy in Huntington’s disease. J
Neuropsychiatry Clin Neurosci. 2010
Summer;22(3):287-94. doi: 10.1176/
appi.neuropsych.22.3.287.
30. Pluck G, Lee KH, Rele R, Spence SA,
Sarkar S, Lagundoye O, et al. Premorbid
and current neuropsychological function
in opiate abusers receiving treatment.
Drug Alcohol Depend. 2012 Jul 1;124(1-
2):181-4. doi: 10.1016/j.drugalc-
dep.2012.01.001. Epub 2012 Jan 28.
31. Benoit M, Andrieu S, Lechowski L,
Gillette-Guyonnet S, Robert PH, Vellas B;
REAL-FR group. Apathy and depression
in Alzheimer’s disease are associated
